Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/18/2010US20100069456 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
03/18/2010US20100069455 Bone model, bone filler and process for producing bone filler
03/18/2010US20100069454 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/18/2010US20100069452 Mineralocorticoid receptor modulators
03/18/2010US20100069451 Salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7, 7a- octahydrobenzo[d]isoxazol-4-one
03/18/2010US20100069450 Salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7, 7a- octahydrobenzo[d]isoxazol-4-one
03/18/2010US20100069449 Novel oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient
03/18/2010US20100069448 Human protein tyrosine phosphatase inhibitors and methods of use
03/18/2010US20100069447 Benzamide derivatives and uses related thereto
03/18/2010US20100069446 L-threonine derivatives of high therapeutic index
03/18/2010US20100069445 Method for the separation of s-(-)-amlodipine from racemic amlodipine
03/18/2010US20100069444 Phenathrenone compounds, compositons and methods
03/18/2010US20100069443 Compound with benzamide skeleton having cyclooxygenase-1 (cox-1)-selective inhibitory activity
03/18/2010US20100069442 Pyrazole compounds that modulate hsp90 activity
03/18/2010US20100069441 Antimicrobial indoline compounds for treatment of bacterial infections
03/18/2010US20100069440 Pyridine non-classical cannabinoid compounds and related methods of use
03/18/2010US20100069438 Anesthesia induction and maintenance drug
03/18/2010US20100069437 Therapeutic agents useful for treating pain
03/18/2010US20100069436 Imidazole compounds having an antiinflammatory effect
03/18/2010US20100069435 Method of selectively introducing amino substituent
03/18/2010US20100069434 Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
03/18/2010US20100069433 Prophylactic and/or therapeutic agent for hyperlipidemia
03/18/2010US20100069432 Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
03/18/2010US20100069431 Imidazopyridine compounds
03/18/2010US20100069430 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
03/18/2010US20100069429 Tea Polyphenol Composition and Method for Producing the Same
03/18/2010US20100069428 Acridone compounds
03/18/2010US20100069427 Oxime and Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds and Methods
03/18/2010US20100069426 Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
03/18/2010US20100069425 Glucocorticoid receptor modulator and methods of use
03/18/2010US20100069424 3-cyano-quinoline derivatives with antiproliferative activity
03/18/2010US20100069423 Use of Chk2 Kinase Inhibitors for Cancer Treatment
03/18/2010US20100069422 Methods and compositions for promoting bone and joint health
03/18/2010US20100069421 Compositions and methods for the treatment of radiation proctosigmoitis
03/18/2010US20100069420 Spiro-piperidine inhibitors
03/18/2010US20100069419 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
03/18/2010US20100069418 3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors
03/18/2010US20100069417 Novel phenyl(4-phenylpyrimidin-2-yl)amine derivatives, their preparation, as medicaments, pharmaceutical compositions and in particular as ikk inhibitors
03/18/2010US20100069416 Azabicyclo [3.1.0] Hexyl Derivatives as Modulators of Dopamine D3 Receptors
03/18/2010US20100069414 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
03/18/2010US20100069413 Pyrimidine and Quinazoline Derivatives
03/18/2010US20100069412 Phosphonoxy quinazoline derivatives and their pharmaceutical use
03/18/2010US20100069411 Cancer treatment method
03/18/2010US20100069410 acyclovir formulations
03/18/2010US20100069409 "novel compounds"
03/18/2010US20100069408 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
03/18/2010US20100069407 CXCR2 inhibitors
03/18/2010US20100069406 Aspartyl protease inhibitors
03/18/2010US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
03/18/2010US20100069404 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
03/18/2010US20100069403 Methods for preventing or treating cardiac arrhythmia
03/18/2010US20100069402 Treatment of Behavioral Disorders
03/18/2010US20100069401 Use of catecholamines and related compounds as anti-angiogenic agents
03/18/2010US20100069400 Methods for treating inflammation and related conditions
03/18/2010US20100069399 Arylpiperazine modulators of d2 receptors, 5-ht1a receptors, and/or 5-ht2a receptors
03/18/2010US20100069398 Combination therapy
03/18/2010US20100069397 Sexual dysfunction compounds
03/18/2010US20100069396 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines
03/18/2010US20100069395 Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid compounds as protein kinase inhibitors
03/18/2010US20100069394 Fast-dissociating dopamine 2 receptor antagonists
03/18/2010US20100069393 Method of treatment and agents useful for same
03/18/2010US20100069392 Combination of HMG-COA Reductase Inhibitors with Phosphodiesterase 4 Inhibitors for the Treatment of Inflammatory Pulmonary Disease
03/18/2010US20100069391 Novel sEH Inhibitors and Their Use
03/18/2010US20100069390 Method of treatment of attention deficit/hyperactivity disorder (ADHD)
03/18/2010US20100069389 Novel forms of reboxetine
03/18/2010US20100069388 N-hydroxyacrylamide compounds
03/18/2010US20100069387 IKK Inhibitors for the Treatment of Endometriosis
03/18/2010US20100069386 Modulators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto
03/18/2010US20100069385 Liquid formulations of phospholipase enzyme inhibitors
03/18/2010US20100069384 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy
03/18/2010US20100069383 Compounds and therapeutical use thereof
03/18/2010US20100069382 Agent for prophylaxis or treatment of alcohol dependence or drug dependence
03/18/2010US20100069381 Gsk-3betainhibitor
03/18/2010US20100069380 Heterocyclic inhibitors of bacterial peptidyl trna hydrolase and uses thereof
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100069378 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
03/18/2010US20100069377 Treatment of female sexual dysfunction by compounds that positively modulate ampa-type glutamate receptors
03/18/2010US20100069376 5-hydroxymethyl-oxazolidin-2-one antibacterials
03/18/2010US20100069375 Indolone-Acetamide Derivatives, Processes for Preparing Them and Their Uses
03/18/2010US20100069374 Tricyclic benzopyrane compound
03/18/2010US20100069373 Substituted lactams as inhibitors of a beta protein production
03/18/2010US20100069372 Compositions and methods for modulating poly(adp-ribose) polymerase activity
03/18/2010US20100069371 Thienopyridine and furopyridine kinase inhibitors
03/18/2010US20100069370 Compounds, compositions and methods
03/18/2010US20100069369 Kinase Inhibitors And Their Uses
03/18/2010US20100069368 Organic Compounds and Their Uses
03/18/2010US20100069367 LXR and FXR Modulators
03/18/2010US20100069366 Antibacterial quinoline derivatives
03/18/2010US20100069365 Diazepane-acetamide derivatives as selective 11B-HSD1 inhibitors
03/18/2010US20100069364 Substituted pyrazoline compounds with acat inhibition activity, their preparation and use as medicaments
03/18/2010US20100069363 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof
03/18/2010US20100069362 Thienopyrimidone compound
03/18/2010US20100069361 Fused Thiazole Derivatives as Kinase Inhibitors
03/18/2010US20100069360 Organic compounds
03/18/2010US20100069359 Constrained spirocyclic compounds as cgrp receptor antagonists
03/18/2010US20100069358 Use of 7-azaindoles in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069357 Pyrimidine compounds, compositions and methods of use
03/18/2010US20100069356 Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
03/18/2010US20100069355 Analogs of Indole-3-Carbinol and Their Use as Agents Against Infection
1 ... 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 ... 7860